EXCELLENT PROGNOSIS of RHEUMATIC MANIFESTATIONS FOLLOWING COVID-19 VACCINATION: 7 MONTHS FOLLOW-UP DATA
Annals of the Rheumatic Diseases
; 81:975-976, 2022.
Article
in English
| EMBASE | ID: covidwho-2009177
bnt 162 vaccine; colchicine; endogenous compound; glucocorticoid; interleukin 1 receptor; adult; adult onset Still disease; adverse drug reaction; aortitis; attention; case report; case study; clinical article; clinical examination; conference abstract; coronavirus disease 2019; disease exacerbation; drug therapy; drug tolerability; follow up; gastrointestinal infection; hospital discharge; hospital patient; hospitalization; human; immunization; immunosuppressive treatment; large vessel vasculitis; lupus erythematosus nephritis; male; nephritis; outpatient; polyarthritis; practice guideline; prognosis; proteinuria; psoriatic arthritis; recurrent disease; remission; rheumatic disease; rheumatic polymyalgia; rheumatoid arthritis; side effect; systemic lupus erythematosus; telemedicine; treatment response; undifferentiated connective tissue disease; university hospital; vaccination; World Health Organization; wrist
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Cohort study
/
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
Annals of the Rheumatic Diseases
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS